The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for CD Klein


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.EBI
German University In Cairo
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.EBI
Heidelberg University
Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.EBI
Heidelberg University
C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.EBI
Heidelberg University
Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity.EBI
Heidelberg University
Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.EBI
Universit£T Heidelberg
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.EBI
Saarland University
Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.EBI
University of Heidelberg
N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors.EBI
Heidelberg University
Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions.EBI
Saarland University
Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases.EBI
Heidelberg University
The spectrum between substrates and inhibitors: Pinpointing the binding mode of dengue protease ligands with modulated basicity and hydrophobicity.EBI
Heidelberg University
Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture.EBI
Heidelberg University
A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.EBI
Heidelberg University
The Medicinal Chemistry of Dengue Virus.EBI
Heidelberg University
Backbone modifications in peptidic inhibitors of flaviviral proteases.EBI
Heidelberg University
Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.EBI
Heidelberg University
Prodrug Activation by a Viral Protease: Evaluating Combretastatin Peptide Hybrids To Selectively Target Infected Cells.EBI
Heidelberg University
Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors.EBI
Heidelberg University
Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.EBI
Australian National University
Beta-aminoketones as prodrugs for selective irreversible inhibitors of type-1 methionine aminopeptidases.EBI
Heidelberg University
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseasesBDB
Zhejiang Dtrm Biopharma
Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.BDB
Leicester Royal Infirmary
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.BDB
Parke-Davis Pharmaceutical Research